Postmenopausal Bleeding After Coronavirus Disease 2019 (COVID-19) Vaccination

被引：0

作者：

Strid, Penelope ^{[1
]}

Abara, Winston E. ^{[1
]}

Clark, Elizabeth ^{[1
]}

Moro, Pedro L. ^{[1
]}

Olson, Christine K. ^{[1
]}

Gee, Julianne ^{[1
]}

机构：

[1] CDCP, COVID 19 Response Team, Atlanta, GA USA

来源：

OBSTETRICS AND GYNECOLOGY | 2024年 / 144卷 / 02期

关键词：

D O I：

10.1097/AOG.0000000000005615

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Reports of postmenopausal bleeding after coronavirus disease 2019 (COVID-19) vaccination were rare, and causes were consistent with known causes of postmenopausal bleeding. We identified U.S. reports of postmenopausal bleeding in the VAERS (Vaccine Adverse Event Reporting System) between December 13, 2020, and December 13, 2021. Among 711,224 VAERS reports after coronavirus disease 2019 (COVID-19) vaccination, during our study period, we identified 554 presumptive postmenopausal bleeding reports; 434 were further classified as verified based on data abstracted from reports and medical records, when available. In the United States, by December 14, 2021, 58.8 million women aged 50 years or older had received at least one dose of a COVID-19 vaccine, corresponding to approximately seven verified VAERS postmenopausal bleeding reports per 1 million women aged 50 years or older who received a COVID-19 vaccine. Reports of postmenopausal bleeding after COVID-19 vaccination in VAERS were rare, and causes of postmenopausal bleeding based on medical record review were consistent with known causes of postmenopausal bleeding.

引用

页码：283 / 287

页数：5

共 6 条

[1]

Centers for Disease Control and Prevention, COVID 19 VACCINATION

[2]

Centers for Disease Control and Prevention, Stay Up to Date with COVID-19 Vaccines

[3]

National Center for Immunization and Respiratory Diseases Archive, COVID-19 Vaccination and Case Trends by Age Group

[4]

Sung S., 2022, Postmenopausal bleeding

[5]

Vaccine Adverse Events Reporting System, 2021, VAERS data use guide

[6]

Vaccine Adverse Events Reporting System, Report an adverse event to VAERS

← 1 →